FindTrial
Sign In

The clinical application of 3D holographic imaging technology in laparoscopic partial nephrectomy

The clinical application of 3D holographic imaging technology in laparoscopic partial nephrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086111
Enrollment
Unknown
Registered
2024-06-25
Start date
2021-05-05
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cell carcinoma

Interventions

experimental group:3D holographic imaging technology-assisted laparoscopic partial nephrectomy
control group:standard laparoscopic partial nephrectomy

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 79 Years

Inclusion criteria

Inclusion criteria: (1) preoperative imaging examination showed a renal tumor with renal score =10; (2) renal tumors in TNM stage T1~2N0M0;

Exclusion criteria

Exclusion criteria: (1) anatomic or functional solitary kidney; (2) multiple renal tumors; (3) bilateral renal tumors; (4) combined with other tumors;

Design outcomes

Primary

MeasureTime frame
renal-functional outcomes;—

Secondary

MeasureTime frame
warm ischemia time;Postoperative complications were classified according to the Clavien–Dindo system;positive surgical margin;operation time;—

Countries

China

Contacts

Public ContactMo Zhang

Shengjing Hospital of China Medical University

peterzhang623@gmail.com+86 189 4025 6868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026